Combination therapy for severe pneumonia from resistant bacteria
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests a Chinese herbal formula combined with virus-based therapy (bacteriophages) to treat severe pneumonia caused by antibiotic-resistant bacteria. It may offer a new option when standard antibiotics fail.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have severe pneumonia caused by certain resistant bacteria (Klebsiella, Acinetobacter, or Pseudomonas).
- You are willing to have a bronchoscopy with lung washing and receive inhaled bacteriophage therapy.
- You agree to provide respiratory samples for testing.
- You are not pregnant or breastfeeding, and you do not have a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach combining a traditional Chinese medicine formula with bacteriophages (viruses that attack bacteria) to treat severe pneumonia caused by antibiotic-resistant bacteria. It aims to see if this combination can improve outcomes for patients who have limited treatment options.
This trial tests a combination of traditional Chinese and Western medicine for adults with severe pneumonia caused by bacteria that are resistant to multiple antibiotics. It aims to see if this combined approach can improve treatment outcomes.
This trial tests whether adding traditional Chinese medicine to standard care helps people with pneumonia caused by bacteria that are hard to treat with many antibiotics. It may offer another option to fight the infection.
This study tests a new treatment that combines regular antibiotics with a special virus that attacks bacteria (called a phage) to fight lung infections that do not respond to standard antibiotics. It aims to see if this combination is safe and might help people with cystic fibrosis who have stubborn lung infections.
This trial tests a new treatment using phages (viruses that kill bacteria) for people with cystic fibrosis who have a chronic pseudomonas lung infection. It aims to see if adding phages to your usual care can help control the infection.
This trial tests whether adding an experimental herbal medicine (NRICM102) to standard antibiotics can help adults hospitalized with community-acquired pneumonia recover faster. It is a phase 2 study, meaning the treatment is still being tested for safety and effectiveness.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.